INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined garlic. Clear

29 studies · page 2 of 2

2013 / Randomized controlled trial

Garlic powder tablets slowed carotid intima-media thickness progression compared to placebo in CAD.

In a trial of 56 patients with coronary artery disease, participants received garlic powder tablets or placebo twice daily for 3 months. Garlic resulted in minor intima-media thickness variation (-0.009 ± 0.007 mm), whereas placebo showed an increase (0.04 ± 0.01 mm), reflecting a significant between-group divergence (p < 0.001). Lipid and lipoprotein concentrations did not differ significantly between treatments.

Mahdavi-Roshan M, Zahedmehr A, Mohammad-Zadeh A, et al. Nutr Health, 2013. PMID 25573347

2012 / Randomized controlled trial

Garlic reduced blood lead and symptoms similarly to d-penicillamine with fewer side effects

A randomized trial in 117 car battery industry workers evaluated garlic (1200 μg allicin three times daily) versus d-penicillamine (250 mg three times daily) for four weeks. Blood lead concentrations dropped significantly in both the garlic group (426.32 to 347.34 μg/L, p=0.002) and d-penicillamine group (417.47 to 315.76 μg/L, p=0.025), without differing significantly between groups. Garlic also improved symptoms such as headaches, irritability, deep tendon reflexes, and systolic blood pressure, while causing significantly fewer side effects than d-penicillamine (p=0.023).

Kianoush S, Balali-Mood M, Mousavi SR, et al. Basic Clin Pharmacol Toxicol, 2012. PMID 22151785

2012 / Masked factorial randomized placebo-controlled trial

Garlic and vitamin supplementation showed non-significant reductions in gastric cancer incidence.

Participants were tracked for 14.7 years following interventions in the Shandong Intervention Trial. Long-term supplementation with garlic or vitamins (C, E, and selenium) was linked to non-statistically significant decreases in gastric cancer incidence and mortality. However, vitamin supplementation significantly lowered combined deaths from gastric or esophageal cancer (hazard ratio = 0.51, 95% CI = 0.30 to 0.87; P = .014).

Ma JL, Zhang L, Brown LM, et al. J Natl Cancer Inst, 2012. PMID 22271764

2001 / Randomized controlled trial

An allicin-containing garlic supplement reduced common cold incidence and symptom duration.

In a 12-week trial, 146 volunteers took either an allicin-containing garlic pill or a placebo daily. Participants receiving garlic experienced significantly fewer colds than those on placebo (24 versus 65, P < .001). The garlic group also recorded fewer total days with viral illness (111 versus 366, P < .05) and shorter average symptom duration (1.52 versus 5.01 days, P < .001).

Josling P Adv Ther, 2001. PMID 11697022

1990 / Intervention trial with repeated testing on different days

Intragastric infusion of garlic (0.75 g or more) and ginger (6 g) increased gastric aspirate DNA content, reflecting surface epithelial cell exfoliation.

Volunteers received intragastric infusions of ginger (2, 4, 6 g) and garlic (0.3, 0.75, 1.5, 3 g uncooked; 3 g cooked) on separate days to assess changes in gastric aspirate DNA content. Infusion of 2 g and 4 g ginger led to non-significant changes, while 6 g ginger significantly increased DNA-p/min by 3.23 +/- 1.02 (P < 0.05). Uncooked garlic at 0.3 g had no significant effect, but doses of 0.75, 1.5, and 3 g significantly increased DNA-p/min by 5.47 +/- 1.63 (P < 0.01), 10.42 +/- 3.46 (P < 0.01), and 29.26 +/- 4.55 (P < 0.001), respectively. Infusion of 3 g cooked garlic also significantly increased DNA-p/min by 21.43 +/- 4.62 (P < 0.001), with no significant difference between cooked and uncooked 3 g garlic.

Desai HG, Kalro RH, Choksi AP Indian J Med Res, 1990. PMID 2370094